Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 2
1995 1
1997 1
1998 1
1999 2
2000 2
2001 1
2002 3
2003 8
2004 3
2005 2
2006 3
2007 5
2008 9
2009 4
2010 9
2011 7
2012 7
2013 15
2014 17
2015 7
2016 7
2017 15
2018 11
2019 6
2020 5
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 24819571

140 results
Results by year
Filters applied: . Clear all
Page 1
Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.
Schoenfelder EN, Faraone SV, Kollins SH. Schoenfelder EN, et al. Pediatrics. 2014 Jun;133(6):1070-80. doi: 10.1542/peds.2014-0179. Epub 2014 May 12. Pediatrics. 2014. PMID: 24819571 Free PMC article.
Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, Biederman J. Wilens TE, et al. Arch Pediatr Adolesc Med. 2008 Oct;162(10):916-21. doi: 10.1001/archpedi.162.10.916. Arch Pediatr Adolesc Med. 2008. PMID: 18838643 Free PMC article.
Can we prevent smoking in children with ADHD: a review of the literature.
Modesto-Lowe V, Danforth JS, Neering C, Easton C. Modesto-Lowe V, et al. Conn Med. 2010 Apr;74(4):229-36. Conn Med. 2010. PMID: 20441004 Review.
Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ. Sikirica V, et al. J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89. doi: 10.18553/jmcp.2012.18.9.676. J Manag Care Pharm. 2012. PMID: 23206211 Free article.
Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K. Hart H, et al. JAMA Psychiatry. 2013 Feb;70(2):185-98. doi: 10.1001/jamapsychiatry.2013.277. JAMA Psychiatry. 2013. PMID: 23247506
Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Coughlin CG, Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Bloch MH. Coughlin CG, et al. J Child Adolesc Psychopharmacol. 2015 Oct;25(8):611-7. doi: 10.1089/cap.2015.0075. Epub 2015 Sep 24. J Child Adolesc Psychopharmacol. 2015. PMID: 26402485 Free PMC article.
The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.
Harty SC, Ivanov I, Newcorn JH, Halperin JM. Harty SC, et al. J Child Adolesc Psychopharmacol. 2011 Aug;21(4):331-9. doi: 10.1089/cap.2010.0074. Epub 2011 Aug 8. J Child Adolesc Psychopharmacol. 2011. PMID: 21823914 Free PMC article.
140 results
Jump to page